InvestorsHub Logo
Followers 438
Posts 45331
Boards Moderated 4
Alias Born 05/11/2008

Re: never-say-die post# 45840

Tuesday, 09/19/2017 10:56:17 AM

Tuesday, September 19, 2017 10:56:17 AM

Post# of 52074
I don´t think so. Here I found the connection between David Esposito and David Dodd. It seems they have a long business relationship already. at least from January 2015 as mentioned below

http://armune.com/aeterna-zentaris-and-armune-bioscience-finalize-co-marketing-agreement-for-apifiny-prostate-cancer-blood-test/

“We are very excited to begin our partnership with Aeterna Zentaris through this initial agreement,” commented David A. Esposito, President and Chief Executive Officer of Armune BioScience. “The experience and expertise of the commercial and research teams at Aeterna Zentaris will be extremely helpful to Armune as we accelerate the growth of APIFINY and develop our autoantibody technology across major areas of unmet need in cancer. In less than eight months on the market, APIFINY has been ordered over 2,500 times as clinicians move beyond PSA-based testing to assess prostate cancer risk. Aeterna Zentaris will help us achieve the full potential of this opportunity.”

http://www.businesswire.com/news/home/20151201005491/en/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.